5 Active Stocks: DR Horton Inc. (NYSE:DHI), SouFun Holdings Ltd. (NYSE:SFUN), SAExploration Holdings, Inc. (NASDAQ:SAEX), Synergetics USA, Inc. (NASDAQ:SURG), Sunesis Pharmaceuticals (NASDAQ:SNSS)

D.R. Horton (NYSE:DHI) has earned a consensus rating of “Hold” from the fifteen brokerages that are covering the stock, Analyst Ratings Net reports. Nine investment analysts have rated the stock with a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. DR Horton Inc. (NYSE:DHI) belongs to Industrial Goods sector. Its net profit margin is 8.20% and weekly performance is -2.92%. On last trading day company shares ended up $24.63. DR Horton Inc. (NYSE:DHI) distance from 50-day simple moving average (SMA50) is 7.61%.

SouFun Holdings Limited (NYSE: SFUN), announced that the strategic cooperation agreements which the Company previously entered into with IFM Investments Limited (NYSE: CTC) (“Century 21 China”) and certain other parties on October 7, 2014 have been terminated in accordance with their terms. Under the agreements, a condition to the Company’s obligations to consummate the transactions contemplated in the agreements was that Century 21 China should have obtained all third party consent within 60 days after the date of the agreements. SouFun Holdings Ltd. (NYSE:SFUN) shares moved down -2.73% in last trading session and ended the day at $8.19. SFUN Gross Margin is 84.00% and its return on assets is 22.00%. SouFun Holdings Ltd. (NYSE:SFUN) quarterly performance is -27.01%.

SAExploration Holdings (NASDAQ:SAEX) CEO Brian A. Beatty purchased 228,805 shares of the company’s stock on the open market in a transaction dated Friday, November 14th. The shares were purchased at an average cost of $4.00 per share, with a total value of $915,220.00. On 09 December, SAExploration Holdings, Inc. (NASDAQ:SAEX) shares increased 20.64% and was closed at $4.50. SAEX EPS growth in last 5 year was 0.00%. SAExploration Holdings, Inc. (NASDAQ:SAEX) year to date (YTD) performance is -49.61%.

On Dec 01, Synergetics USA, Inc. (NASDAQ:SURG) announced today that it will host a conference call on Wednesday, December 10, 2014 at 4:00 p.m. Central Time (5:00 p.m. Eastern) to review the Company’s results for the fiscal first quarter ended October 31, 2014. A news release announcing the first quarter’s results will be issued on Wednesday, December 10, 2014, after market close. Synergetics USA, Inc. (NASDAQ:SURG) ended the last trading day at $3.55. Company weekly volatility is calculated as 2.21% and price to cash ratio as 5.85. Synergetics USA, Inc. (NASDAQ:SURG) showed a weekly performance of 3.65%.

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) announced the presentation of updated results from an ongoing Phase 1b/2 University of Texas MD Anderson Cancer Center-sponsored trial of vosaroxin in combination with decitabine in older patients with previously untreated acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). The results will be presented today in an oral session titled “Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: New Drugs II” taking place from 10:30 AM to 12:00 PM PT at the 56th American Society of Hematology Annual Meeting in San Francisco, California. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) shares remains unchanged in last trading session and ended the day at $2.31. SNSS return on assets is -89.70%. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) quarterly performance is -68.70%.